| pubmed-article:9808914 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9808914 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9808914 | lifeskim:mentions | umls-concept:C0376238 | lld:lifeskim |
| pubmed-article:9808914 | lifeskim:mentions | umls-concept:C0003402 | lld:lifeskim |
| pubmed-article:9808914 | lifeskim:mentions | umls-concept:C0871161 | lld:lifeskim |
| pubmed-article:9808914 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:9808914 | pubmed:dateCreated | 1998-11-23 | lld:pubmed |
| pubmed-article:9808914 | pubmed:abstractText | 50 mg of Saffron dissolved in 100 ml of milk was administered twice a day to 20 human subjects. Lipoprotein oxidation susceptibility (LOS) was estimated initially and after 3 and 6 weeks. There was a constant decrease in LOS during this period. From a mean of 66.4 +/- 3.18 it decreased to 38.3 +/- 2.8 in 10 healthy individuals and from 76.0 +/- 3.72 to 48.8 +/- 3.0 in 10 patients of CAD. The significant fall (P < 0.001) in LOS indicates the potential of Saffron as an antioxidant. | lld:pubmed |
| pubmed-article:9808914 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9808914 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9808914 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9808914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9808914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9808914 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9808914 | pubmed:month | May | lld:pubmed |
| pubmed-article:9808914 | pubmed:issn | 0019-5359 | lld:pubmed |
| pubmed-article:9808914 | pubmed:author | pubmed-author:BordiaAA | lld:pubmed |
| pubmed-article:9808914 | pubmed:author | pubmed-author:VermaS KSK | lld:pubmed |
| pubmed-article:9808914 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9808914 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:9808914 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9808914 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9808914 | pubmed:pagination | 205-7 | lld:pubmed |
| pubmed-article:9808914 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:meshHeading | pubmed-meshheading:9808914-... | lld:pubmed |
| pubmed-article:9808914 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9808914 | pubmed:articleTitle | Antioxidant property of Saffron in man. | lld:pubmed |
| pubmed-article:9808914 | pubmed:affiliation | Department of Medicine and Indigenous Drug Research Centre, RNT Medical College, Udaipur. | lld:pubmed |
| pubmed-article:9808914 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9808914 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9808914 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9808914 | lld:pubmed |
